Opin vísindi

COPA syndrome in an Icelandic family caused by a recurrent missense mutation in COPA

COPA syndrome in an Icelandic family caused by a recurrent missense mutation in COPA


Title: COPA syndrome in an Icelandic family caused by a recurrent missense mutation in COPA
Author: Jensson, Brynjar O.
Hansdottir, Sif   orcid.org/0000-0002-8485-1106
Árnadottir, Guðný A.
Sulem, Gerald
Kristjansson, Ragnar   orcid.org/0000-0002-3678-5693
Oddsson, Asmundur   orcid.org/0000-0002-4606-5163
Benónísdóttir, Stefanía
Jónsson, Hákon   orcid.org/0000-0001-6197-494X
Helgason, Agnar
Sæmundsdóttir, Jóna
... 15 more authors Show all authors
Date: 2017-11-14
Language: English
Scope: 129
University/Institute: Háskóli Íslands
University of Iceland
School: Félagsvísindasvið (HÍ)
School of Social Sciences (UI)
Verkfræði- og náttúruvísindasvið (HÍ)
School of Engineering and Natural Sciences (UI)
Heilbrigðisvísindasvið (HÍ)
School of Health Sciences (UI)
Department: Félags- og mannvísindadeild (HÍ)
Faculty of Social and Human Sciences (UI)
Læknadeild (HÍ)
Faculty of Medicine (UI)
Series: BMC Medical Genetics;18(1)
ISSN: 1471-2350
DOI: 10.1186/s12881-017-0490-8
Subject: Genetics; Erfðagreining; Lungnasjúkdómar; Erfðafræði; Rannsóknir
URI: https://hdl.handle.net/20.500.11815/470

Show full item record

Citation:

Jensson, B. O., Hansdottir, S., Arnadottir, G. A., Sulem, G., Kristjansson, R. P., Oddsson, A., . . . Stefansson, K. (2017). COPA syndrome in an Icelandic family caused by a recurrent missense mutation in COPA. BMC Medical Genetics, 18(1), 129. doi:10.1186/s12881-017-0490-8

Abstract:

Background: Rare missense mutations in the gene encoding coatomer subunit alpha (COPA) have recently been shown to cause autoimmune interstitial lung, joint and kidney disease, also known as COPA syndrome, under a dominant mode of inheritance. Case presentation: Here we describe an Icelandic family with three affected individuals over two generations with a rare clinical presentation of lung and joint disease and a histological diagnosis of follicular bronchiolitis. We performed whole-genome sequencing (WGS) of the three affected as well as three unaffected members of the family, and searched for rare genotypes associated with disease using 30,067 sequenced Icelanders as a reference population. We assessed all coding and splicing variants, prioritizing variants in genes known to cause interstitial lung disease. We detected a heterozygous missense mutation, p.Glu241Lys, in the COPA gene, private to the affected family members. The mutation occurred de novo in the paternal germline of the index case and was absent from 30,067 Icelandic genomes and 141,353 individuals from the genome Aggregation Database (gnomAD). The mutation occurs within the conserved and functionally important WD40 domain of the COPA protein. Conclusions: This is the second report of the p.Glu241Lys mutation in COPA, indicating the recurrent nature of the mutation. The mutation was reported to co-segregate with COPA syndrome in a large family from the USA with five affected members, and classified as pathogenic. The two separate occurrences of the p.Glu241Lys mutation in cases and its absence from a large number of sequenced genomes confirms its role in the pathogenesis of the COPA syndrome. Keywords: COPA syndrome, Lung disease, Arthritis, Immune dysregulation, Case report

Rights:

This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Files in this item

This item appears in the following Collection(s)